497 related articles for article (PubMed ID: 26246787)
1. Pharmacological approaches to the challenge of treatment-resistant depression.
Ionescu DF; Rosenbaum JF; Alpert JE
Dialogues Clin Neurosci; 2015 Jun; 17(2):111-26. PubMed ID: 26246787
[TBL] [Abstract][Full Text] [Related]
2. Lithium or an atypical antipsychotic drug in the management of treatment-resistant depression: a systematic review and economic evaluation.
Edwards SJ; Hamilton V; Nherera L; Trevor N
Health Technol Assess; 2013 Nov; 17(54):1-190. PubMed ID: 24284258
[TBL] [Abstract][Full Text] [Related]
3. Evidence for the benefits of nonantipsychotic pharmacological augmentation in the treatment of depression.
Chang CM; Sato S; Han C
CNS Drugs; 2013 May; 27 Suppl 1():S21-7. PubMed ID: 23712796
[TBL] [Abstract][Full Text] [Related]
4. A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough?
Dodd S; Bauer M; Carvalho AF; Eyre H; Fava M; Kasper S; Kennedy SH; Khoo JP; Lopez Jaramillo C; Malhi GS; McIntyre RS; Mitchell PB; Castro AMP; Ratheesh A; Severus E; Suppes T; Trivedi MH; Thase ME; Yatham LN; Young AH; Berk M
World J Biol Psychiatry; 2021 Sep; 22(7):483-494. PubMed ID: 33289425
[TBL] [Abstract][Full Text] [Related]
5. Ketamine: Future Treatment For Unresponsive Depression?
Frere M; Tepper J
Ir Med J; 2016 Sep; 109(8):453. PubMed ID: 28124853
[TBL] [Abstract][Full Text] [Related]
6. Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved Therapeutics.
de Sousa RT; Zanetti MV; Brunoni AR; Machado-Vieira R
Curr Neuropharmacol; 2015; 13(5):616-35. PubMed ID: 26467411
[TBL] [Abstract][Full Text] [Related]
7. Ketamine for treatment-resistant unipolar depression: current evidence.
Mathew SJ; Shah A; Lapidus K; Clark C; Jarun N; Ostermeyer B; Murrough JW
CNS Drugs; 2012 Mar; 26(3):189-204. PubMed ID: 22303887
[TBL] [Abstract][Full Text] [Related]
8. Use of Ketamine in Elderly Patients with Treatment-Resistant Depression.
Medeiros da Frota Ribeiro C; Riva-Posse P
Curr Psychiatry Rep; 2017 Nov; 19(12):107. PubMed ID: 29138992
[TBL] [Abstract][Full Text] [Related]
9. The integrative management of treatment-resistant depression: a comprehensive review and perspectives.
Carvalho AF; Berk M; Hyphantis TN; McIntyre RS
Psychother Psychosom; 2014; 83(2):70-88. PubMed ID: 24458008
[TBL] [Abstract][Full Text] [Related]
10. Relapse prevention in treatment-resistant major depressive disorder with rapid-acting antidepressants.
Singh JB; Fedgchin M; Daly EJ; Drevets WC
Adv Pharmacol; 2020; 89():237-259. PubMed ID: 32616208
[TBL] [Abstract][Full Text] [Related]
11. Comparing augmentation with non-antidepressants over sticking to antidepressants after treatment failure in depression: a naturalistic study.
Köhler S; Unger T; Hoffmann S; Steinacher B; Fydrich T; Bschor T
Pharmacopsychiatry; 2013 Mar; 46(2):69-76. PubMed ID: 23093475
[TBL] [Abstract][Full Text] [Related]
12. Understanding the genetic aspects of resistance to antidepressants treatment.
Alqahtani AM; Kumarappan C; Kumar V; Srinivasan R; Krishnaraju V
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7784-7795. PubMed ID: 32744705
[TBL] [Abstract][Full Text] [Related]
13. Perspectives for therapy of treatment-resistant depression.
Papp M; Cubala WJ; Swiecicki L; Newman-Tancredi A; Willner P
Br J Pharmacol; 2022 Sep; 179(17):4181-4200. PubMed ID: 34128229
[TBL] [Abstract][Full Text] [Related]
14. Psychological therapies for treatment-resistant depression in adults.
Ijaz S; Davies P; Williams CJ; Kessler D; Lewis G; Wiles N
Cochrane Database Syst Rev; 2018 May; 5(5):CD010558. PubMed ID: 29761488
[TBL] [Abstract][Full Text] [Related]
15. Off-label use of ketamine for treatment-resistant depression in clinical practice: European perspective.
López-Díaz Á; Murillo-Izquierdo M; Moreno-Mellado E
Br J Psychiatry; 2019 Aug; 215(2):447-448. PubMed ID: 31030677
[TBL] [Abstract][Full Text] [Related]
16. Association of Treatment-Resistant Depression With Patient Outcomes and Health Care Resource Utilization in a Population-Wide Study.
Lundberg J; Cars T; Lööv SÅ; Söderling J; Sundström J; Tiihonen J; Leval A; Gannedahl A; Björkholm C; Själin M; Hellner C
JAMA Psychiatry; 2023 Feb; 80(2):167-175. PubMed ID: 36515938
[TBL] [Abstract][Full Text] [Related]
17. Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment-resistant depression.
Martinotti G; Dell'Osso B; Di Lorenzo G; Maina G; Bertolino A; Clerici M; Barlati S; Rosso G; Di Nicola M; Marcatili M; d'Andrea G; Cavallotto C; Chiappini S; De Filippis S; Nicolò G; De Fazio P; Andriola I; Zanardi R; Nucifora D; Di Mauro S; Bassetti R; Pettorruso M; McIntyre RS; Sensi SL; di Giannantonio M; Vita A;
Bipolar Disord; 2023 May; 25(3):233-244. PubMed ID: 36636839
[TBL] [Abstract][Full Text] [Related]
18. Overview of treatment-resistant depression.
Li CT
Prog Brain Res; 2023; 278():1-23. PubMed ID: 37414489
[TBL] [Abstract][Full Text] [Related]
19. Early improvement and response to antidepressant medications in adults with major depressive disorder. Meta-analysis and study of a sample with treatment-resistant depression.
Olgiati P; Serretti A; Souery D; Dold M; Kasper S; Montgomery S; Zohar J; Mendlewicz J
J Affect Disord; 2018 Feb; 227():777-786. PubMed ID: 29254066
[TBL] [Abstract][Full Text] [Related]
20. Can Machine Learning help us in dealing with treatment resistant depression? A review.
Pigoni A; Delvecchio G; Madonna D; Bressi C; Soares J; Brambilla P
J Affect Disord; 2019 Dec; 259():21-26. PubMed ID: 31437696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
